KO — filing
0001628280-25-046054 · 265,149 characters of text, split into 1 sections
Filed with the SEC · open the original
Item 1A. Risk Factors
What to look forWhat management is required to admit could go wrong. Written by lawyers, but the ordering and any newly added risk are informative.
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, which could materially affect our business, financial condition or future results. The risks described in this report and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, could also materially adversely affect our business, financial condition or future result s.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended September 26, 2025 by the Company or any "affiliated purchaser" of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period Total Number of Shares Purchased 1
Average
Price Paid
Per Share Total Number of
Shares Purchased as Part of the Publicly
Announced Plan 2
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
June 28, 2025 through July 25, 2025 788,277 $ 69.96 786,700 70,128,134
July 26, 2025 through August 22, 2025 871,700 69.66 871,700 69,256,434
August 23, 2025 through September 26, 2025 860,781 67.50 860,400 68,396,034
Total 2,520,758 $ 69.02 2,518,800
1 The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the 2019 Plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
2 In February 2019, the Company publicly announced that our Board of Directors had authorized a plan ("2019 Plan") for the Company to purchase up to 150 million shares of our common stock. This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended September 26, 2025, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K .
54
Item 6. Exhibits
Excerpt. This section runs to 17,094 characters — read the whole filing at the SEC.
Not found in this filing
Business, Legal proceedings, Market for the shares, Management's discussion, Market risk, Financial statements. Filers format their reports differently, and this reader would rather say it could not find a section than show you the wrong one.
Educational material, not investment advice. Nothing here is a recommendation to buy or sell anything.